These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 12871039)

  • 1. Novel immunotherapeutic strategies for invasive fungal disease.
    van Spriel AB
    Curr Drug Targets Cardiovasc Haematol Disord; 2003 Sep; 3(3):209-17. PubMed ID: 12871039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy of Fungal Infections.
    Datta K; Hamad M
    Immunol Invest; 2015; 44(8):738-76. PubMed ID: 26575463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current antifungal drugs and immunotherapeutic approaches as promising strategies to treatment of fungal diseases.
    Nami S; Aghebati-Maleki A; Morovati H; Aghebati-Maleki L
    Biomed Pharmacother; 2019 Feb; 110():857-868. PubMed ID: 30557835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal immunotherapy and immunomodulation: a double-hitter approach to deal with invasive fungal infections.
    Hamad M
    Scand J Immunol; 2008 Jun; 67(6):533-43. PubMed ID: 18397201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promising immunotherapy against fungal diseases.
    Posch W; Steger M; Wilflingseder D; Lass-Flörl C
    Expert Opin Biol Ther; 2017 Jul; 17(7):861-870. PubMed ID: 28429626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy for fungal infections.
    Armstrong-James D; Harrison TS
    Curr Opin Microbiol; 2012 Aug; 15(4):434-9. PubMed ID: 22884572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of efficacy trials of cytokines in combination with antifungal drugs.
    Kullberg BJ; Oude Lashof AM; Netea MG
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S218-23. PubMed ID: 15546121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapeutic approaches for fungal infections.
    Williams TJ; Harvey S; Armstrong-James D
    Curr Opin Microbiol; 2020 Dec; 58():130-137. PubMed ID: 33147544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Spanish Paediatric Infectious Diseases Society consensus document on the treatment of fungal infections based on the immune response].
    Martín A; Soler-Palacín P; Español T; Dapena JL; Urrutia E; Navarro M; Alvez F; Figueras C;
    An Pediatr (Barc); 2010 Dec; 73(6):362.e1-8. PubMed ID: 20638349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy for fungal infections.
    Segal BH; Kwon-Chung J; Walsh TJ; Klein BS; Battiwalla M; Almyroudis NG; Holland SM; Romani L
    Clin Infect Dis; 2006 Feb; 42(4):507-15. PubMed ID: 16421795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging New Targets for the Treatment of Resistant Fungal Infections.
    Liu N; Tu J; Dong G; Wang Y; Sheng C
    J Med Chem; 2018 Jul; 61(13):5484-5511. PubMed ID: 29294275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive immune therapy for fungal infections.
    Casadevall A; Pirofski LA
    Clin Infect Dis; 2001 Oct; 33(7):1048-56. PubMed ID: 11528579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host immune reactivity and antifungal chemotherapy: the power of being together.
    Romani L
    J Chemother; 2001 Aug; 13(4):347-53. PubMed ID: 11589476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy against invasive mold infections.
    Antachopoulos C; Katragkou A; Roilides E
    Immunotherapy; 2012 Jan; 4(1):107-20. PubMed ID: 22150004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fungal infections: Immune defense, immunotherapies and vaccines.
    Loh JT; Lam KP
    Adv Drug Deliv Rev; 2023 May; 196():114775. PubMed ID: 36924530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokines in the treatment of fungal infections.
    Kullberg BJ; van 't Wout JW
    Biotherapy; 1994; 7(3-4):195-210. PubMed ID: 7865351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing invasive fungal disease in immunocompromised patients.
    Maertens J; Bryan J
    Future Microbiol; 2010 Dec; 5(12):1775-9. PubMed ID: 21155660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host Control of Fungal Infections: Lessons from Basic Studies and Human Cohorts.
    Lionakis MS; Levitz SM
    Annu Rev Immunol; 2018 Apr; 36():157-191. PubMed ID: 29237128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of immunoreconstitution in the management of refractory opportunistic fungal infections.
    Roilides E; Dignani MC; Anaissie EJ; Rex JH
    Med Mycol; 1998; 36 Suppl 1():12-25. PubMed ID: 9988488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The exciting future of antifungal therapy.
    Neely MN; Ghannoum MA
    Eur J Clin Microbiol Infect Dis; 2000 Dec; 19(12):897-914. PubMed ID: 11205627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.